E
ENDRA Life Sciences Inc. (NDRA)
NCM – Real vaqt narxi. Valyuta: USD
5.81
+0.74 (14.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
5.81
+0.74 (14.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
ENDRA Life Sciences Inc. klinik diagnostik ultratovush qobiliyatlarini yaxshilash texnologiyalarini ishlab chiqadi. Kompaniya termoakustik kuchaytirilgan ultratovush texnologiyasini ishlab chiqish bilan shug'ullanadi, bu esa radio chastotasi kabi impulsli energiya manbasidan foydalanib, to'qimalarga chuqur energiya uzatadi va non-alkogolli yog'li jigar kasalligini davolashda, shuningdek, to'qimalar tarkibini, haroratni nazorat qilish, tomirlarni tasvirlash va to'qimalarning perfuziya tahlilida foydalanish uchun yuqori kontrastli tasvirlarni yaratish uchun ultratovush to'lqinlarini hosil qiladi. ENDRA Life Sciences Inc. 2007-yilda tashkil etilgan bo'lib, shtab-kvartirasi Michigan shtatining Ann Arbor shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Mr. Alexander Y. Tokman | CEO & Chairman |
| Mr. Idan Steinberg | Head of Engineering |
| Mr. Richard Jacroux | CFO & Secretary |
| Mr. Scott Sober | Head of Operations |
| Mr. Ziad Rouag J.D. | Head of Regulatory & Clinical Affairs |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-21 | 8-K | ea0287103-8k_endra.htm |
| 2026-03-31 | 10-K | ea0283994-10k_endra.htm |
| 2026-03-25 | 8-K | ea0283331-8k_endra.htm |
| 2025-12-15 | 8-K | ea0269386-8k_endra.htm |
| 2025-11-28 | 8-K | ea0267731-8k_endra.htm |
| 2025-11-14 | 10-Q | ea0265291-10q_endra.htm |
| 2025-11-06 | S-3 | ea0263382-s3_endra.htm |
| 2025-10-28 | DEFA14A | shn_defa14a.htm |
| 2025-10-24 | D | |
| 2025-10-23 | 8-K | endra_8k.htm |